Cytonus Therapeutics
UEI: UBM9DERRCXZ9
• CAGE: 8DAU4
Overview
Awardee Type
Parent
Keywords
Biotechnology, Cell Therapy
Name
Cytonus Therapeutics
Website
Headquarters
Columbus, OH
United States
United States
Most Recent Award
Oct. 1, 2024
Calculating
Federal grant recipient
CYTONUS THERAPEUTICS INC.
dba CYTONUS THERAPEUTICS INC
(UEI UBM9DERRCXZ9, CAGE 8DAU4)
is headquartered in Columbus OH.
Its primary registered NAICS is 541714 Research and Development in Biotechnology (except Nanobiotechnology).
The corporation
was founded in August 2018 and
federally registered in
August 2019.
Federal Award Analysis
Cytonus Therapeutics federal award history
$-
Contracts
$-
Subcontracts
$-
Grants
$-
Subgrants
$-
Total
No Results
Calculating
Calculating
No Results
Calculating
Calculating
No Results
Calculating
Calculating
| Year | Contracts | Subcontracts | Grants | Subgrants |
|---|
No Results
Calculating
Calculating
No Results
Calculating
Calculating
Federal Registration and Certifications
Legal Name
CYTONUS THERAPEUTICS INC.
DBA
CYTONUS THERAPEUTICS INC
UEI
UBM9DERRCXZ9
CAGE Code
8DAU4
SBA Certifications
None
Self Certifications
Self-Certified Small Disadvantaged Business
Entity Structure
Corporate Entity (Not Tax Exempt)
Purpose of Registration
Federal Contracts and Assistance
Date Founded
Aug. 21, 2018
Initial Registration
Aug. 8, 2019
Last Registration
Aug. 14, 2024
Registration Activation
Aug. 14, 2024
Registration Expiration
Aug. 12, 2025
Fiscal Year End
December 31
Reported Entity Types
For Profit Organization
State of Incorporation
DE
Country of Incorporation
USA
Employees
<500
Accepts Credit Cards
No
People
Vendor contacts at Cytonus Therapeutics
Grant Awards
Cytonus Therapeutics direct grants
Subgrant Awards
Cytonus Therapeutics subgrant awards
State and Local Awards
Cytonus Therapeutics state and local contract awards
Click here to learn more about State and Local award data coverageTeaming Partners
Disclosed awardee sub and prime contract and grant relationships
Cytonus Therapeutics